Associated Papers
Genomic profiling of AKT1 and NRAS mutations using NGS in Egyptian hepatocellular carcinoma.
Mohmed MM et al.
Discover Oncology, 2025
Somatic Mutation Profiling and Therapeutic Landscape of Breast Cancer in the MENA Region.
Velayutham D et al.
Cells, 2025
41294844 (PubMed )
Supplement: cells-14-01791-s001.zip › cells-3910392-supplementary › Table_S2.xlsx › Table_S3
Subclonal TP53 and KRAS variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALL.
Kempter T et al.
Blood Advances, 2025
39808796 (PubMed )
Supplement: BLOODA_ADV-2024-014209-mmc1.pdf
Identification and analysis of oncogenic non-synonymous single nucleotide polymorphisms in the human NRAS gene: An exclusive in silico study.
Mozibullah M et al.
Journal, Genetic Engineering & Biotechnology, 2024
38797553 (PubMed )
Supplement: mmc1.xlsx › Table_1
Exploring somatic mutations in BRAF, KRAS, and NRAS as therapeutic targets in Saudi colorectal cancer patients through massive parallel sequencing and variant classification.
Aljuhani TA et al.
Frontiers in Pharmacology, 2024
Histology-based molecular profiling improves mutation detection for advanced thyroid cancer.
Eszlinger M et al.
Genes, Chromosomes & Cancer, 2021
Select a paper to view details